Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer
Katherine O’Connor; Deniz Erkok; Josephine A. Wright; Paige Steppe; Kate R. Barratt; Laura Vrbanac; Dan L. Worthley; Susan L. Woods; Jeff Hasty Current Treatment Options in Rheumatology
· Springer Nature
· 2026-11-18
Аннотация
Communications Medicine, Published online: 18 November 2026; doi:10.1038/s43856-026-01992-x ED Summary: O’Connor et al. use a patient-derived organoid co-culture platform to evaluate engineered bacterial therapies for colorectal cancer and capture strain- and patient-specific responses. Both bacteria preferentially colonise tumours, but attenuated Salmonella shows stronger colonisation and biological effects than E. coli Nissle.
Katherine O’Connor; Deniz Erkok; Josephine A. Wright; Paige Steppe; Kate R. Barratt; Laura Vrbanac; Dan L. Worthley; Susan L. Woods; Jeff Hasty. Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer. // Current Treatment Options in Rheumatology. – 2026. – URL: https://www.nature.com/articles/s43856-026-01992-x
Katherine O’Connor; Deniz Erkok; Josephine A. Wright; Paige Steppe; Kate R. Barratt; Laura Vrbanac; Dan L. Worthley; Susan L. Woods; Jeff Hasty (2026). Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer. Current Treatment Options in Rheumatology. https://www.nature.com/articles/s43856-026-01992-x
Katherine O’Connor; Deniz Erkok; Josephine A. Wright; Paige Steppe; Kate R. Barratt; Laura Vrbanac; Dan L. Worthley; Susan L. Woods; Jeff Hasty. “Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer.” Current Treatment Options in Rheumatology, 2026.
@article{Hasty2026,
title = {Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer},
author = {Hasty, Katherine O’Connor; Deniz Erkok; Josephine A. Wright; Paige Steppe; Kate R. Barratt; Laura Vrbanac; Dan L. Worthley; Susan L. Woods; Jeff},
journal = {Current Treatment Options in Rheumatology},
year = {2026},
url = {https://www.nature.com/articles/s43856-026-01992-x}
}
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....